Baguet, T., Verhoeven, J., de Vos, F., & Goethals, I. (2018). P01.129 Cost-effectiveness of [18F] FET for therapy assessment of temozolomide for patients with glioblastoma in a Belgian healthcare setting. Neuro Oncol.
Chicago-tyylinen lähdeviittausBaguet, T., J. Verhoeven, F. de Vos, ja I. Goethals. "P01.129 Cost-effectiveness of [18F] FET for Therapy Assessment of Temozolomide for Patients With Glioblastoma in a Belgian Healthcare Setting." Neuro Oncol 2018.
MLA-viiteBaguet, T., J. Verhoeven, F. de Vos, ja I. Goethals. "P01.129 Cost-effectiveness of [18F] FET for Therapy Assessment of Temozolomide for Patients With Glioblastoma in a Belgian Healthcare Setting." Neuro Oncol 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.